MUSC Health Teams Up with Glytec to Transform Diabetes Care
In an exciting development for health care, MUSC Health is partnering with Glytec, a pioneer in diabetes and insulin management technology. This collaboration aims to revolutionize diabetes care in hospitals and clinics under the MUSC umbrella, significantly enhancing clinical outcomes and safety for patients.
Addressing the Diabetes Epidemic
Diabetes affects over 37 million Americans, and many more are at risk. This partnership comes at a critical time, as the number of individuals requiring insulin therapy continues to rise. Glytec’s advanced software solutions are specifically designed to offer efficient management of diabetes, which is crucial, especially as new regulations from the Centers for Medicare and Medicaid Services (CMS) emphasize the need for effective patient glycemic control.
Integration with Existing Systems
After a thorough review of potential solutions, MUSC leadership and IT professionals chose Glytec for its seamless integration capabilities with the existing electronic medical record (EMR) system, EPIC. By adopting Glytec’s sophisticated platform, MUSC Health is set to provide enhanced clinical decision support, facilitating smoother insulin therapy and minimizing fluctuations in glycemic management. This innovative approach will empower clinicians to make better-informed decisions, which is expected to lead to improved patient results.
Leadership Insights
Dr. Danielle Scheurer, the chief quality officer at MUSC Health, expressed enthusiasm for the collaboration, stating, "Our partnership with Glytec is a vital step forward in our mission to enhance diabetes care across the MUSC network. By integrating innovative technology into our workflow, we can manage inpatient and outpatient diabetes care more effectively, ultimately benefiting our patients significantly." This insight underscores the commitment of MUSC to leverage technology in advancing health care delivery.
A Commitment to Innovative Care
MUSC Health's dedication to providing quality care is evident in their proactive approach to addressing the complexities of diabetes management. Utilizing Glytec's FDA-cleared software will ensure that the hospitals within the MUSC network are well-equipped to comply with the latest CMS requirements while delivering exceptional patient care.
Patrick Cua, Glytec's CEO, shared his excitement regarding the collaboration, saying, "We look forward to working alongside MUSC to support their innovation in diabetes management. Our software is positioned to assist MUSC clinicians in delivering tailored and effective care to a significant number of patients, ensuring they receive optimal support and resources for their health challenges." This partnership embodies a shared vision of using advanced technology to meet the rising demands of patient care.
About Glytec
Glytec stands at the forefront of diabetes management solutions with its cloud-based insulin management platform, currently trusted by over 350 hospitals. Their software not only aims to improve patient care outcomes but also works to reduce hospital stays and optimize clinician workflows. By integrating with EMRs, it provides vital clinical decision support and enables real-time patient monitoring.
About MUSC Health
Founded over 190 years ago, MUSC Health is the premier academic health system in its region with a constant focus on research, education, and high-quality patient care. Their commitment to training the next generation of healthcare professionals and providing top-level care has earned MUSC recognition as a leader in the health sector. With more than 31,000 members including experts, physicians, and scientists, the institution is dedicated to pioneering advancements in medical care.
Frequently Asked Questions
1. What is the main goal of the MUSC and Glytec partnership?
The partnership aims to enhance diabetes management and improve clinical outcomes through innovative software solutions.
2. How does Glytec’s software benefit patients?
Glytec’s technology provides advanced decision support and streamlines insulin therapy, ultimately improving patient outcomes and safety.
3. Why is diabetes management important in hospitals?
Effective diabetes management is crucial as many hospitalized patients require insulin therapy, making proper care essential for their recovery.
4. What role does technology play in this partnership?
Technology is integral to integrating data-driven approaches into workflows, enabling clinicians to make informed decisions for patient care.
5. How many hospitals currently utilize Glytec's platform?
Over 350 hospitals trust Glytec’s technology for managing diabetes and insulin therapies.
